Sensus Healthcare, Inc.

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 09:35:14 2024-04-30 am EDT			5-day change	1st Jan Change
3.55 ^USD	+4.72%		+4.41%	+50.42%

Feb. 08	Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
Feb. 08	Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Sensus Healthcare, Inc. authorizes a Buyback Plan.

August 07, 2023

The Board of Directors of Sensus Healthcare, Inc. has authorized a buyback plan on August 8, 2023.

Latest news about Sensus Healthcare, Inc.

Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 08	CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M	Feb. 08	MT
Sensus Healthcare Announces Directors Changes	Feb. 01	CI
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 23	CI
Sensus Healthcare, Inc. Appoints Michael Sardano as A Director, Effective February 1, 2024	Jan. 18	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	Nov. 13	CI
Transcript : Sensus Healthcare, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $3.9M	Nov. 09	MT
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego	23-09-26	CI
Sensus Healthcare, Inc.(NasdaqCM:SRTS) dropped from S&P Global BMI Index	23-09-18	CI
Sensus Healthcare, Inc. Enters into A Credit Agreement with Comerica Bank	23-09-14	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on March 9, 2022.	23-08-11	CI
Sensus Healthcare Launches $3 Million Stock Buyback Program; Shares Surge 15% Midday	23-08-08	MT
Sensus Healthcare, Inc. announces an Equity Buyback for $3 million worth of its shares.	23-08-08	CI
Sensus Healthcare, Inc. authorizes a Buyback Plan.	23-08-07	CI
HC Wainwright Adjusts Price Target on Sensus Healthcare to $8 From $10, Keeps Buy Rating	23-08-07	MT
Earnings Flash (SRTS) SENSUS HEALTHCARE Reports Q2 Revenue $4.5M	23-08-03	MT
Transcript : Sensus Healthcare, Inc., Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
Sensus Healthcare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
Sensus Healthcare Completes Installation of Its First Srt System in Ireland	23-07-25	CI
Sensus Healthcare Says SRT-100's Limited Study Shows Potential Effectiveness, Safety in Treating Cutaneous Mast Cell Tumors	23-05-17	MT
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on March 9, 2022.	23-05-12	CI
Sector Update: Health Care Stocks Slipping Late Thursday	23-05-04	MT

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-09 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Sensus Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.39 USD

Average target price

7.5 USD

Spread / Average Target

+121.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
SENSUS HEALTHCARE, INC.	+50.42%	55.58M
SARTORIUS AG	-15.19%	19.22B
QUIDELORTHO CORPORATION	-46.57%	2.63B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.50%	1.86B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.58%	1.66B
BIOTAGE AB	+25.65%	1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-8.67%	1.05B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.91%	894M
REVENIO GROUP OYJ	-3.90%	740M
VAREX IMAGING CORPORATION	-18.63%	687M

Medical Diagnostic & Testing Equipment